BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17434163)

  • 21. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Kazemier KM; van Wering ER; Janka-Schaub GE; Pieters R
    Haematologica; 2005 Dec; 90(12):1697-9. PubMed ID: 16330447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
    Li S; Juco J; Mann KP; Holden JT
    Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
    Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
    Leuk Lymphoma; 2001 Aug; 42(4):675-82. PubMed ID: 11697497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anemia and survival in childhood acute lymphoblastic leukemia.
    Teuffel O; Stanulla M; Cario G; Ludwig WD; Rottgers S; Schafer BW; Zimmermann M; Schrappe M; Niggli FK
    Haematologica; 2008 Nov; 93(11):1652-7. PubMed ID: 18815194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCR-ABL, ETV6-RUNX1 and E2A-PBX1: prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients.
    Jiménez-Morales S; Miranda-Peralta E; Saldaña-Alvarez Y; Perez-Vera P; Paredes-Aguilera R; Rivera-Luna R; Velázquez-Cruz R; Ramírez-Bello J; Carnevale A; Orozco L
    Leuk Res; 2008 Oct; 32(10):1518-22. PubMed ID: 18455790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
    Schmidt K; Seeger K; Scheibenbogen C; Bender R; Abdulla M; Süssmilch S; Salama A; Moldenhauer A
    J Leukoc Biol; 2009 Mar; 85(3):563-73. PubMed ID: 19129484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid surface antigen expression in adult acute lymphoblastic leukemia.
    Guyotat D; Campos L; Shi ZH; Charrin C; Treille D; Magaud JP; Fiere D
    Leukemia; 1990 Sep; 4(9):664-6. PubMed ID: 1697640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness.
    Guillaume N; Penther D; Vaida I; Gruson B; Harrivel V; Claisse JF; Capiod JC; Lefrere JJ; Damaj G
    Int J Lab Hematol; 2011 Feb; 33(1):92-6. PubMed ID: 20666852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
    Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
    Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The application of conventional cytogenetics, FISH, and RT-PCR to detect genetic changes in 70 children with ALL.
    Soszynska K; Mucha B; Debski R; Skonieczka K; Duszenko E; Koltan A; Wysocki M; Haus O
    Ann Hematol; 2008 Dec; 87(12):991-1002. PubMed ID: 18633615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor.
    Akahane K; Inukai T; Inaba T; Kurosawa H; Look AT; Kiyokawa N; Fujimoto J; Goto H; Endo M; Zhang X; Hirose K; Kuroda I; Honna H; Kagami K; Goi K; Nakazawa S; Sugita K
    Leukemia; 2010 Apr; 24(4):865-9. PubMed ID: 20147975
    [No Abstract]   [Full Text] [Related]  

  • 32. Pediatric acute lymphoblastic leukemia: there is no TEL-ing what wonders lie ahead.
    Sandoval C
    Leuk Res; 2010 Apr; 34(4):418-9. PubMed ID: 19892401
    [No Abstract]   [Full Text] [Related]  

  • 33. CD163 expression in leukemia cutis.
    Harms PW; Bandarchi B; Ma L
    J Cutan Pathol; 2010 Sep; 37(9):953-7. PubMed ID: 20175823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ETV6/CBFA2 fusions in childhood B-cell precursor acute lymphoblastic leukemia with myeloid markers.
    Rafi SK; El Gebaly H; Qumsiyeh MB
    Diagn Mol Pathol; 2000 Dec; 9(4):184-9. PubMed ID: 11129441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [MIC categorization of acute lymphoblastic leukemia with myeloid surface antigen expression].
    Wu WL; Liang JY; Zhu MQ; Xue YQ; Chen ZX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):754-6. PubMed ID: 18457267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia.
    Pakakasama S; Kajanachumpol S; Kanjanapongkul S; Sirachainan N; Meekaewkunchorn A; Ningsanond V; Hongeng S
    Int J Lab Hematol; 2008 Aug; 30(4):286-91. PubMed ID: 18665825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia.
    Pui CH; Rubnitz JE; Hancock ML; Downing JR; Raimondi SC; Rivera GK; Sandlund JT; Ribeiro RC; Head DR; Relling MV; Evans WE; Behm FG
    J Clin Oncol; 1998 Dec; 16(12):3768-73. PubMed ID: 9850020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
    Vitale A; Guarini A; Ariola C; Meloni G; Perbellini O; Pizzuti M; De Gregoris C; Mettivier V; Pastorini A; Pizzolo G; Vignetti M; Mandelli F; Foà R
    Haematologica; 2007 Mar; 92(3):342-8. PubMed ID: 17339183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of CD66c expression in childhood acute lymphoblastic leukemia.
    Kiyokawa N; Iijima K; Tomita O; Miharu M; Hasegawa D; Kobayashi K; Okita H; Kajiwara M; Shimada H; Inukai T; Makimoto A; Fukushima T; Nanmoku T; Koh K; Manabe A; Kikuchi A; Sugita K; Fujimoto J; Hayashi Y; Ohara A
    Leuk Res; 2014 Jan; 38(1):42-8. PubMed ID: 24231528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparision of the apoptotic effects on lymphoblasts and on increase of myeloid lineage cells of a short-time, high-dose methylprednisolone and the conventional-dose prednisolone treatments in children with acute lymphoblastic leukemia.
    Erduran E; Tekelioglu Y; Karakas T; Gedik Y; Mert FM
    Pediatr Hematol Oncol; 2006; 23(7):587-98. PubMed ID: 16928654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.